Esophageal Squamous Cell Carcinoma Clinical Trials in Fuzhou, Fujian
5 recruitingFuzhou, Fujian, China
Showing 1–5 of 5 trials
Recruiting
Phase 2
Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC
Esophageal Squamous Cell Carcinoma
Fujian Medical University Union Hospital90 enrolled1 locationNCT06601309
Recruiting
Tumor Regression Grade As Predictor of Adjuvant Therapy
Esophageal Squamous Cell Carcinoma (ESCC)
Fujian Medical University Union Hospital400 enrolled1 locationNCT06710665
Recruiting
Phase 2
Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC
Esophageal Squamous Cell CarcinomaImmunotherapyBiomarkers
Fujian Medical University Union Hospital48 enrolled1 locationNCT06510660
Recruiting
Phase 2
A Study of Sintilimab Combined With Chemotherapy for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma
Fujian Cancer Hospital30 enrolled1 locationNCT06463834
Recruiting
Phase 3
Study Compare Adjuvant Chemotherapy, Chemoradiotherapy and Surgery Alone for pN1-2(pT1b-3N1-2M0) Esophageal Carcinoma
Esophageal Squamous Cell Carcinoma
Fujian Medical University Union Hospital819 enrolled1 locationNCT04009265